Why Is Healthcare Due Diligence Different from Standard Business Due Diligence
Financial due diligence for a healthcare practice is fundamentally more complex than due diligence for a standard business acquisition because healthcare revenue is not simply a function of prices and volume. It is a function of payer contracts with varying reimbursement rates, clinical documentation that determines coding levels and therefore revenue per encounter, regulatory frameworks that constrain billing practices and compensation structures, and provider productivity patterns that may change dramatically under new ownership. A buyer acquiring a $5M dental practice is not just buying revenue. They are buying a portfolio of payer relationships, a provider workforce with specific productivity patterns, a compliance history that carries forward, and a patient base whose loyalty may or may not survive a change in ownership.
The ecosystem of parties reviewing your practice's financials during a transaction compounds this complexity. The buyer's internal team evaluates strategic fit and operational integration. Their quality of earnings provider, typically a Big Four or regional accounting firm, rebuilds your financials from scratch to validate reported EBITDA and identify adjustments. Lenders providing acquisition financing require financial statements that meet bank-grade standards and demonstrate sufficient debt service coverage. And if the buyer is a hospital system, private equity platform, or dental service organization, their compliance team reviews billing practices, coding accuracy, and physician compensation arrangements for Stark Law and Anti-Kickback Statute exposure. Each of these reviewers cares about different but overlapping aspects of your financial story, and a gap in any area can stall or kill the deal.
The financial stakes of poor preparation are measurable. Healthcare practice transactions in the private equity and hospital acquisition market have averaged 6x to 10x EBITDA for physician practices and 4x to 7x EBITDA for dental practices over the past three years. On a practice with $1.5M in normalized EBITDA, the difference between a 6x and an 8x multiple is $3M in purchase price. Practices that enter due diligence with incomplete records, messy financials, or unresolved compliance issues routinely see their multiple reduced by 1.0x to 2.0x during the diligence process, representing hundreds of thousands to millions of dollars in lost value.
How Do You Demonstrate That Your Financial Statements Are Buyer-Grade
The first and most fundamental step in due diligence preparation is ensuring that your financial statements can withstand external scrutiny without requiring the buyer to rebuild them. Buyer-grade financial statements are not the same as tax-return-grade financial statements. Tax returns are prepared to minimize taxable income, which often means aggressive deductions, inconsistent capitalization policies, and revenue recognition that defers income where possible. Buyer-grade financial statements, by contrast, should present a clear and consistent picture of the practice's true economic performance.
At a minimum, buyer-grade financial statements require a consistent chart of accounts that has been used without material changes for at least three years, allowing period-over-period comparison. Revenue should be recognized on an accrual basis and reconciled monthly to deposits, remittance advice, and accounts receivable. Expenses should be classified consistently, with clear distinctions between operating expenses, owner-specific expenses, and non-recurring items. The balance sheet should be fully reconciled monthly, with all bank accounts, credit cards, loans, and intercompany balances tied to supporting documentation.
The most common financial statement failures in healthcare practice due diligence include commingling personal and business expenses (such as personal vehicle payments, family member compensation, personal insurance, and lifestyle expenses run through the practice), inconsistent treatment of provider compensation where a physician-owner takes a below-market salary to inflate EBITDA or an above-market salary to minimize taxes, unreconciled accounts receivable where the aging report does not tie to the general ledger, and cash basis accounting that obscures the true timing of revenue and expenses. Each of these failures requires the buyer's quality of earnings team to make adjustments that introduce uncertainty, and uncertainty in due diligence always flows against the seller in the form of a lower purchase price or more onerous deal terms.
What Does Revenue Quality Analysis Look Like in a Healthcare Practice
Revenue quality is the single most scrutinized area of healthcare due diligence because healthcare revenue is inherently more complex and less predictable than revenue in most other industries. A buyer is not simply asking "how much revenue does this practice generate?" They are asking whether the revenue is real (supported by actual claims and collections rather than accrual estimates), whether it is collectible (reflected in reasonable AR aging and low bad debt expense), whether it is sustainable (not dependent on a single payer, a single provider, or a temporary market condition), and whether it is replicable under new ownership (not dependent on the selling physician's personal relationships or unique clinical reputation).
Payer mix analysis is the starting point of revenue quality evaluation. A practice that derives 60% or more of its revenue from a single payer carries concentration risk that buyers will discount. If that concentrated payer is Medicaid, the discount is particularly steep because Medicaid reimbursement rates are typically 40% to 60% below commercial rates and are subject to state budget pressures that can reduce rates further. A diversified payer mix with 30% to 40% commercial, 25% to 35% Medicare, 15% to 20% Medicaid, and 10% to 15% self-pay is generally considered healthy for most practice types. The specific benchmarks vary by specialty: orthopedic practices typically have higher commercial mix, while primary care practices in underserved areas may have higher Medicaid mix.
Beyond payer mix, buyers analyze reimbursement rate trends by payer over the past three years. If commercial rates have been flat or declining while costs have increased, the practice's margin is compressing, and the buyer's financial model will reflect that compression. If Medicare rates for the practice's primary procedure codes are scheduled to change under pending CMS rule-making, the buyer will adjust their projections accordingly. Practices that can demonstrate stable or increasing reimbursement rates across their major payers, supported by current contracts and historical trend data, present a more compelling revenue story than those where rate data is unavailable or shows deterioration.
Accounts receivable aging by payer provides critical insight into the collectibility of recognized revenue. Healthy AR aging for a healthcare practice shows 70% to 80% of AR in the 0-to-30-day bucket, 10% to 15% in the 31-to-60-day bucket, and less than 10% over 60 days. If the practice has significant AR over 90 or 120 days, the buyer will discount or write off that AR in their purchase price calculation and will investigate whether the aged AR reflects systemic billing problems, payer disputes, or patient collections issues that will persist after closing.
Why Is Provider Productivity the Hidden Variable in Healthcare Valuations
Provider productivity drives revenue in every healthcare practice, and it is the single variable that is most likely to change after an acquisition. When a physician-owner sells their practice and transitions to an employment arrangement, their productivity may decline because the financial incentives change. When a dental practice rolls into a DSO, the associate dentists may leave because they prefer independent practice. When a behavioral health group is acquired, the therapists may resist standardized scheduling protocols that increase session volume. Each of these scenarios represents a revenue risk that buyers analyze through the lens of provider productivity data.
The standard metric for physician productivity is work RVUs (Relative Value Units) generated per provider per year, benchmarked against MGMA (Medical Group Management Association) or AMGA (American Medical Group Association) survey data. A primary care physician generating 4,500 work RVUs per year is at approximately the 50th percentile nationally, while one generating 6,000 work RVUs is at the 75th to 90th percentile. Buyers prefer providers who are productive but not unsustainably so. A physician at the 95th percentile of productivity raises the question of whether that pace can be maintained, and whether the revenue is dependent on a level of effort that the provider will not sustain after the sale.
The financial impact of productivity analysis on purchase price is direct. If a two-physician practice generates $3M in collections and the buyer's analysis suggests that post-acquisition productivity will decline 15% due to compensation restructuring and scheduling changes, the buyer models $2.55M in go-forward revenue, and the purchase multiple is applied to EBITDA based on the lower revenue assumption. That 15% productivity decline assumption could reduce the purchase price by $400,000 to $600,000 on a practice valued at $3M to $4M. Practices that document provider productivity by RVU, by payer, and by procedure code, and that demonstrate stable productivity trends over at least 24 months, eliminate one of the buyer's biggest sources of uncertainty.
How Should You Present Physician Compensation for Due Diligence
Physician compensation analysis in healthcare due diligence serves two purposes. First, it determines the normalized expense base for EBITDA calculation. If physician-owners are paying themselves below market rate to inflate EBITDA, the buyer will add back the difference to normalize expenses upward, reducing the apparent profitability. If physician-owners are paying themselves above market rate, the buyer will normalize downward, but the seller will also need to demonstrate that post-acquisition compensation at market rates will retain the providers. Second, compensation analysis evaluates regulatory compliance. Physician compensation arrangements that exceed fair market value or that are based on referral volume rather than personal productivity may implicate the Stark Law (physician self-referral) or the Anti-Kickback Statute, creating contingent liability that buyers will either price into the deal or use as a basis for walking away.
The standard for physician compensation analysis is a fair market value opinion from a qualified valuation firm, benchmarked to MGMA or SullivanCotter survey data and updated within the past 24 months. The opinion should document the compensation methodology (salary, productivity-based, equal split, or hybrid), the benchmark percentile used, the rationale for any deviation from median compensation, and the total compensation including base salary, bonus, benefits, retirement contributions, and any non-cash compensation such as personal expenses paid by the practice. Practices that present comprehensive, current compensation documentation eliminate weeks of back-and-forth during diligence and demonstrate the kind of financial discipline that commands premium valuations.
What Billing and Coding Risks Do Buyers Investigate During Healthcare Due Diligence
Financial due diligence in healthcare is inseparable from billing and coding compliance because billing errors create both financial risk (recoupment liability) and regulatory risk (False Claims Act exposure). Buyers will typically engage a coding consultant to review a sample of claims, usually 50 to 100 charts stratified by procedure type and payer, to assess coding accuracy and documentation adequacy. If that review identifies a systematic overcoding pattern, such as consistently billing E/M Level 4 (99214) when documentation supports Level 3 (99213), the buyer will extrapolate the error rate across the full claims volume to estimate the financial exposure.
The financial impact of coding errors in due diligence is amplified by the False Claims Act's treble damages provision. A billing error that resulted in $200,000 in overpayments could theoretically create $600,000 in False Claims Act liability, plus penalties of $11,181 to $27,894 per false claim under 2024 penalty amounts. Even when False Claims Act litigation is unlikely, the theoretical exposure gives buyers leverage to negotiate significant price reductions. Practices that conduct annual internal coding audits, maintain coding accuracy rates above 95%, and can produce audit results for the past three years demonstrate that billing risk is managed rather than unknown, which preserves deal value.
How Do You Normalize EBITDA and Present Add-Backs That Buyers Will Accept
EBITDA normalization is the financial exercise that most directly determines purchase price, and it is the area where sellers most frequently leave money on the table by failing to identify legitimate add-backs or by presenting add-backs without adequate documentation. Normalized EBITDA starts with reported net income and adds back interest, taxes, depreciation, and amortization, then adjusts for non-recurring expenses, above-market owner compensation, personal expenses run through the practice, and any other items that do not reflect the ongoing economic reality of the business.
Common healthcare-specific add-backs include above-market physician-owner compensation (the difference between actual compensation and the 50th to 60th percentile MGMA benchmark for the specialty), one-time legal or consulting fees related to the transaction itself, non-recurring recruitment costs or signing bonuses, personal expenses such as personal vehicle payments, personal insurance, or family member compensation for no-show positions, and rent paid to a related-party landlord above fair market rates for the space. Each add-back must be documented with supporting evidence: pay stubs, contracts, receipts, and market data that substantiate the claim.
The quality of the add-back documentation directly affects how much of the add-back the buyer's QoE team will accept. Well-documented add-backs with clear supporting evidence are typically accepted at 80% to 100% of the claimed amount. Poorly documented add-backs, or those that strain credibility, may be accepted at 30% to 50% or rejected entirely. On a practice with $1.2M in reported net income and $400,000 in potential add-backs, the difference between 90% acceptance and 50% acceptance is $160,000 in normalized EBITDA, which at a 7x multiple translates to $1.12M in purchase price impact.
What Should a Healthcare-Ready Data Room Contain
The final element of due diligence preparation is organizing all of this information into a structured, professional data room that guides the buyer through your practice's financial and operational story. A healthcare-ready data room should be organized into logical sections: corporate and governance documents, financial statements and tax returns (three years minimum), revenue cycle and payer information, provider information and compensation, compliance and regulatory documents, real estate and equipment, employee and HR documents, and legal and insurance documents.
Within the financial section, the data room should include monthly financial statements for at least 36 months, annual tax returns for at least three years, a detailed revenue breakout by payer, provider, and service line, AR aging reports as of each month-end for the trailing 12 months, a schedule of normalized EBITDA with supporting documentation for each add-back, a working capital analysis with 12 months of historical data, and a debt schedule listing all outstanding obligations with terms and maturity dates.
The quality of data room organization has a measurable impact on deal outcomes. Buyers and their advisors report that well-organized data rooms accelerate due diligence by 30 to 45 days, reduce the volume of supplemental information requests by 40% to 60%, and create a positive impression that influences how aggressively the buyer negotiates on price. In contrast, a chaotic data room signals that the practice's financial management is equally disorganized, which causes buyers to increase their risk assumptions and reduce their offer accordingly.
How Northstar Financial Advisory Supports Healthcare Due Diligence Preparation
At Northstar Financial Advisory, our healthcare practice advisory work focuses on transforming the financial records and systems of physician practices, dental groups, and behavioral health organizations into due diligence-ready assets that command premium valuations. Our engagements typically begin 6 to 12 months before the practice expects to receive a letter of intent, giving us sufficient time to clean up financial statements, build EBITDA normalization schedules with bulletproof documentation, develop payer mix and revenue quality analyses, organize a professional data room, and address any compliance or financial control gaps that would otherwise become negotiating leverage for the buyer.
If you are considering a partnership, roll-up, or sale in the next one to three years, or if you have already received interest from a buyer and want to ensure your financial story is ready for scrutiny, the time to prepare is before the first due diligence request arrives. The practices that achieve the strongest outcomes are those that treat due diligence preparation as a strategic initiative rather than a reactive exercise.